Retinitis Pigmentosa Case Study: Dr. Dharan Krishna Reports Vision Improvement After Stem Cell Treatment
Dr. Dharan Krishna from India was living with retinitis pigmentosa, a genetic eye disorder that causes progressive degeneration of the retina. This case study follows his two-dose stem cell treatment at Stem Cell Cure India and the changes in visual acuity he reported afterwards.
- Patient
- Dr. Dharan Krishna
- Country
- India
- Condition
- Retinitis pigmentosa (RP)
- Treatment
- Stem cell therapy
- Treatment centre
- Stem Cell Cure India
Patient background
Dr. Dharan Krishna from India was suffering from Retinitis Pigmentosa (RP), a genetic eye disorder that causes progressive degeneration of the retina and can significantly affect vision over time.
Seeking additional treatment possibilities for his condition, he approached Stem Cell Cure India and underwent its stem cell treatment procedure.
Understanding the patient’s condition
Retinitis Pigmentosa is an inherited retinal disorder that affects the light-sensitive cells of the retina. It can lead to progressive vision loss and difficulties with night vision and peripheral vision.
As the disease progresses, patients may experience significant visual impairment that can affect their everyday activities and quality of life.
Initial vision assessment before stem cell treatment
Before undergoing stem cell treatment, the patient’s visual assessment showed the following results:
| Eye | Vision before treatment |
|---|---|
| Right eye | 6/24 |
| Left eye | 6/36 (P) |
These measurements provided the baseline for evaluating the patient’s vision during subsequent follow-up assessments.
Stem cell treatment journey
Dr. Dharan Krishna underwent the complete two-dose stem cell treatment procedure at Stem Cell Cure India.
According to the treatment provider’s description, the patient started reporting encouraging changes in his vision approximately one week after his first stem cell treatment course. He subsequently completed both doses as part of his treatment programme.
Stem cell therapy, also known as regenerative medicine, is an emerging field being investigated for its potential to support tissue repair and cellular function.
Patient video: experience after stem cell treatment.
Vision assessment after stem cell treatment
Following the treatment, the patient’s reported visual assessment showed the following changes:
| Eye | Before treatment | After treatment |
|---|---|---|
| Right eye | 6/24 | 6/18 |
| Left eye | 6/36 (P) | 6/24 |
- The reported results indicate improvement in the recorded visual acuity measurements in both eyes.
- The change from 6/24 to 6/18 in the right eye and from 6/36 (P) to 6/24 in the left eye was encouraging for the patient and his treatment team.
Patient satisfaction and future expectations
Dr. Dharan Krishna was reportedly very satisfied with the changes observed in his vision following the treatment.
The treatment provider expressed hope that further improvements might be observed over the next 4–6 months through continued monitoring and follow-up assessments. However, future visual outcomes cannot be guaranteed and will depend on the patient’s individual clinical condition.
Conclusion
Dr. Dharan Krishna’s journey represents an individual experience of exploring stem cell treatment for Retinitis Pigmentosa.
The reported changes in visual acuity following the two-dose treatment programme provide an encouraging account of his treatment journey. His experience highlights the importance of continued research into emerging approaches for inherited retinal disorders, along with regular ophthalmological assessments and appropriate clinical care.
Frequently asked questions
Is stem cell therapy an established treatment for retinitis pigmentosa?
No. Stem cell treatment for retinitis pigmentosa remains investigational. This page describes one patient’s experience and does not establish that the treatment reverses the condition.
Will every patient get the same result as Dr. Dharan Krishna?
No. Individual results vary and depend on each patient’s clinical condition. Patients should consult a qualified retinal specialist before considering experimental treatment.
Do you accept international patients?
Yes. International patients can start with an online consultation and share their medical reports for review.